lAight is an innovative, non-invasive therapy for acute abscesses including hidradenitis suppurativa/ acne inversa.
What physicians say about lAight®
“The lAight® therapy is a promising alternative for the treatment of hidradenitis suppurativa and I am delighted to be able to provide it for my patients. We can treat the disease now without surgical interventions, long-term and non-invasive. The results of the lAight® therapy are very positive and my patients are relieved to have found a working treatment.”
Dr. Zeynep Potente, Aestetic and plastic surgeon.
“It is my goal to give HS patients a normal life. I offer a special consultation hour for patients with chronic abscesses and hidradenitis suppurativa. After only 7 months I already witnessed so many distinct and visible successes that I am very happy to have included this gently new form of therapy into my practice. The overwhelmingly positive feedback is a great encouragement for me.”
Dr. med. Uwe Kirschner, Dermatologist and venereologist
“We are familiar with the ordeal of the HS patients. We are happy to be able to provide a treatment that is a good supplementation to a surgical intervention.”
Gerhard Rothenaicher, Surgeon
“The combination of the lAight® therapy with a special treatment of wounds in our WundZentrum offers a good possibility and great therapeutic option for patients with HS.”
Dr. Peter Kandzorra, Surgeon
University Medical Center of the University MainzUnder the supervision of
Univ.-Prof. Dr. med. Esther von Stebut-BorschitzSenior Physician, Assistant Professor TransMed Research School,
Head of Programming, Expert in inflammatory Dermatosis,
Since October 2017: Director of the clinic and policlinic for dermatology and venerology of the University Medical Center of Cologne
Henry Ford Health System, Detroit, USAUnder the supervision of
Iltefat Hamzavi, M.D., FAADDirector Researcher Initiated Studies, Dermatological
Expert in Photodermatology und Laser-Technology for Hidradenitis suppurativa/Acne inversa und Vitiligo
The lAight®therapy was also presented in Detroit at the SHSA 2017-Symposium on Hidradenitis Suppurativa Advances in November 2017.